# Transpire Bio Inc. – FDA Inspection, Oct 1, 2025

Source: https://www.keypedia.com/records/fda_inspections/transpire-bio-inc/56f779d3-8c38-4b9e-9d6c-f5880c304c40
Source feed: FDA_Inspections

> FDA inspection 1285042 of Transpire Bio Inc., October 01, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1285042
- Company Name: Transpire Bio Inc.
- Inspection Date: 2025-10-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1290840 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/transpire-bio-inc/d0689059-c203-411b-a0a1-500639fc5424)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-lalama/5ebc4da1-62ac-4b15-89a8-e18b0606e0ff)
- [Investigator](https://www.keypedia.com/people/mickell-smith/ef92e41a-a16b-488a-a217-b10b54bb4f73)

Company: https://www.keypedia.com/companies/transpire-bio-inc/f2ab3def-2519-4172-8194-14a7f372db87

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9
